1Zhao J,Wu R,Au A,et al.Determination of HER-2 gene amplification by chromogenic in situ hybridization(CISH)in archival breast carcinoma[J].Mod Pathol,2002,15(6):657-665. 被引量：1
2Dowsett M,Bartlett J,Ellis IO,et al.Correlation between immunohistochemistry (Hercep Test) and fluorescence in situ hybridization(FISH) for HER-2 in 426 breast carcinomas from 37centres[J].J Pathol,2003,199(4):418-423. 被引量：1
4Ellis IO,Dowsett M,Bartlett J,et al.Recommendations for HER2 testing in the UK[J].J Clin Pathol,2000,53(12):890-892. 被引量：1
5Thor A.HER-2 a discussion of testing approaches in the USA[J].Ann Oncol,2001,12(1):101-107. 被引量：1
6Cell markers and Cytogenetics Committees College of American Pathologists.Clinical laboratory assays for HER2/neu amplification and overexpression:quality assurance,standardization,and proficiency testing[J].Arch Pathol Lab Med,2002,126 (7):803-808. 被引量：1
二级参考文献11
1Moch H Kononen T K allionemi OP et al Tissue microarrays what will they bring to lolecular abnd abatuomic pathology ?Adv Anat Patol 2001,8:14-20 被引量：1
2Ekins R，Chu FW. Microarrays: their origins and applications. Trends Biotechnol， 1999, 17, 217-218. 被引量：1
3Wooster R. Cancer classification with DNA microarrays is less more? Trends Genet， 2000， 16:327-329. 被引量：1
4Sallinen SL, Sallinen PK, Haapasalo HK, et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res，2000，60:6617-6622. 被引量：1
5Richter J, Wagner U, Kononen J. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol， 2000，157:787-794. 被引量：1
6Barlund M, Monni O, Kononen J, et al. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. CancerRes, 2000，60:5340-5344. 被引量：1
7Bubendorf L, Kononen J, Koivisto P, et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res，1999， 59:803-806. 被引量：1
8Moch H, Schraml P, Bubendorf L, et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol，1999，154:981-986. 被引量：1
9Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res，1999，5:1966-1975 被引量：1
10Battfora H The multutumor (sausage)tissue block :novel method for immunohistochemical antibody testing Lab Inveat ,1986,55:244-248 被引量：1
4Krishnamurti U, Sliverman J F. HER-2 in breast cancer: a review and update [ J ]. Adv Anat Pathol, 2014,21 (2) : 100 - 7. 被引量：1
5Figueroa-Magalhes M C, Jelovac D, Connolly R M, Wolff A C. Treatment of HER-2-positive breast cancer [ J ]. Breast, 2014,23 (2) :128 -36. 被引量：1
6Nunes C B, Rocha R M, Reis-Filho J S, et al. Comparative analy- sis of six different antibodies against HER-2 including the novel rabbit momoclonal antibody ( SP3 ) and chromogenic in situ hybrid- ization in breast carcinomas[ J]. J Clin Pathol, 2008,61 (8):934 -8. 被引量：1
7Skaland I, Nordhus M, Gudlaugsson E, et al. Evaluation of 5 Dif- ferent Labeled Polymer Immunohistochemical Detection Systems [ J ]. Appl Immunohistochem M ol Morphol, 2010,18 ( 1 ) :90 - 6. 被引量：1
